Credence Formulations Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 5.00 Cr
as on 15-12-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -39.44%
(FY 2020)
- Profit -21.13%
(FY 2020)
- Ebitda -24.61%
(FY 2020)
- Net Worth 136.84%
(FY 2020)
- Total Assets -34.96%
(FY 2020)
About Credence Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gaddam Nehru, Sai Bhavani, Sravankumar Gone, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2013PTC089018
- Company No.
089018
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Credence Formulations?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sai Bhavani  | Director | 28-Oct-2017 | Current |
| Gaddam Nehru | Director | 17-Oct-2016 | Current |
| Sravankumar Gone | Additional Director | 22-Mar-2021 | Current |
| Prashanthi Maramreddy | Additional Director | 22-Mar-2021 | Current |
| Shravan Yeluvaka | Additional Director | 22-Mar-2021 | Current |
Financial Performance of Credence Formulations.
Credence Formulations Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 39.44% decrease. The company also saw a substantial fall in profitability, with a 21.13% decrease in profit. The company's net worth Soared by an impressive increase of 136.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Credence Formulations?
In 2020, Credence Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Regina Medicorp Private LimitedActive 11 years 9 monthsGaddam Nehru and Sai Bhavani are mutual person
- Ckr Chemco Private LimitedActive 11 months 6 days
Sravankumar Gone and Shravan Yeluvaka are mutual person
- Salvar Constructions Private LimitedActive 3 years 6 months
Prashanthi Maramreddy is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Credence Formulations?
Credence Formulations has a workforce of 2 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Credence Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Credence Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
